Delivery Order SPE2DB22D1106-SPE2DB23FEPD7
Award Date 6/27/23
Potential Completion Date 6/28/23
Potential Value $918
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $278,180 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml syringes. As part of the Defense Logistics Agency's pharmaceutical supply chain management program, the delivery order calls for Amerisourcebergen to provide Emgality, a monoclonal antibody for preventive treatment of migraine, to support Department of Defense medical treatment facilities. Performance will take place at Amerisourcebergen's distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,088.94 to AmerisourceBergen Drug Corp for the supply of Emgality 300 mg (100 mg x 3 syringes). This firm fixed-price, non-set-aside delivery order was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025. The product will be delivered to Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary distribution center. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Emgality 120 mg/mL pen injectors, valued at $1,556.10. This is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, and represents a non-competitive set-aside award. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This...
- The Defense Logistics Agency awarded a $417 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. As the prime contractor, Amerisourcebergen will supply the migraine treatment medication to the DLA, the logistics combat support agency of the Department of Defense, under a one-day period of performance from August 2nd to August 3rd, 2023 in Conshohocken, Pennsylvania. No subcontractors or set aside designations were indicated. The DLA...
- The Defense Logistics Agency (DLA) awarded a $1,506.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors on December 11, 2025, with an ultimate completion date of December 12, 2025. This is a non-set-aside competitive award issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from...
- The Defense Logistics Agency awarded a $3,804 delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. This firm fixed price order is being fulfilled under an existing Prime Vendor contract vehicle and will provide the requested pharmaceutical products to DLA from July 3 to July 5, 2023. Amerisourcebergen will perform the order from its facility in Conshohocken, Pennsylvania and no subcontractors or set aside designations were specified. The DLA manages the...
- The Defense Logistics Agency awarded a $7,769.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Emgality 300mg injections. As the prime contractor, Amerisourcebergen will supply the pharmaceutical products to the DLA under a one-day period of performance from August 29th to 30th, 2023. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. No subcontractors or set aside designations were indicated. The DLA manages the Department of...
- The Defense Logistics Agency awarded a delivery order valued at $7,257.28 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Emgality 300 mg (100 mg x3 syringe/mL). This competitive award, which carries no set-aside designation, is structured as a firm fixed-price contract with an ultimate completion date of September 4, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary place of...
- The Defense Logistics Agency awarded a $11,044.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emgality 300 mg (100 mg x 3 syringe/ml) on June 2, 2025, with completion scheduled for June 3, 2025. This non-set-aside award was competitively procured and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Emgality 120 mg/mL pen injectors, with a ceiling value of $1,037.40. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Emgality is a CGRP monoclonal antibody indicated for migraine prevention, representing a...